Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,060 | 31,831 | 19,365 | 21,736 | 7,468 |
| Receivables | 556 | 581 | 592 | 644 | 644 |
| TOTAL | $34,015 | $32,899 | $20,102 | $22,582 | $8,281 |
| Non-Current Assets | |||||
| PPE Net | 591 | 635 | 660 | 494 | 431 |
| Intangibles | 19,092 | 19,092 | 19,092 | 19,092 | 19,092 |
| Other Non-Current Assets | 544 | 590 | 624 | 673 | 727 |
| TOTAL | $20,227 | $20,317 | $20,376 | $20,259 | $20,250 |
| Total Assets | $54,242 | $53,216 | $40,478 | $42,841 | $28,531 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,080 | 2,350 | 2,640 | 1,659 | 1,999 |
| Other current liabilities | 61 | 36 | 77 | 34 | 7 |
| TOTAL | $1,358 | $2,614 | $2,943 | $1,925 | $2,286 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 345 | 381 | 426 | 475 | 523 |
| TOTAL | $379 | $425 | $480 | $485 | $537 |
| Total Liabilities | $1,737 | $3,039 | $3,423 | $2,410 | $2,823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,953 | 5,711 | 4,343 | 4,343 | 4,343 |
| Common Shares | 71 | 69 | 53 | 53 | 36 |
| Retained earnings | -244,908 | -243,415 | -240,745 | -237,250 | -235,260 |
| TOTAL | $52,505 | $50,177 | $37,055 | $40,431 | $25,708 |
| Total Liabilities And Equity | $54,242 | $53,216 | $40,478 | $42,841 | $28,531 |